Company Filing History:
1 out of 2 
1 out of 1 Years Active: 1985
Title: Eduard V Gjulling: Innovator in Pharmaceutical Compounds
Introduction
Eduard V Gjulling is a notable inventor based in Kyiv, Ukraine. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative compounds that exhibit various biological activities. His work has implications for immunomodulation, antibacterial, and antiviral applications.
Latest Patents
Eduard V Gjulling holds a patent for a novel class of compounds known as 6-Phenyl-2,3,5,6-tetrahydroimidazo-[2,1-b]-thiazole derivatives. This patent includes compounds with the general formula: ##STR1##, where R can be CH₂ COOCH₃, CH₂ COOC₁₀ H₂₁, or CH₂ CONH₂, and X is Br. These compounds are recognized for their immunomodulating, antibacterial, and antiviral properties, showcasing Gjulling's innovative approach to drug development.
Career Highlights
Throughout his career, Eduard V Gjulling has worked with esteemed institutions such as the Institute of Organic Chemistry of the Academy of Sciences of the Ukrainian SSR and the Kyiv Scientific Research Institute of Otolaryngology. His experience in these organizations has allowed him to develop and refine his research in pharmaceutical compounds.
Collaborations
Eduard has collaborated with notable colleagues, including Larisa A Djugovskaya and Dmitry I Zabolotny. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Eduard V Gjulling's contributions to the field of pharmaceuticals through his innovative compounds highlight his role as a significant inventor. His work continues to impact the development of new therapeutic agents.